Bharat Biotech's Covaxin Safe But Need Phase 3 Results to Assess Effectiveness, Says Lancet

The report also mentioned that phase 2 results do not permit efficacy assessments and further corroboration with phase 3 safety results was required.

from Top India News- News18.com https://ift.tt/3btmOEj